Gankyrin stimulates glycolysis and glutaminolysis via upregulating c-Myc and activating β-catenin signaling to enhance tumorigenesis, metastasis, and treatment resistance in human HCC [46]. Here, MYC is linked to hepatocellular carcinoma.